Primary and Secondary Immune Response
B cells:
Upon 1st exposure to an antigen, activated B cells proliferate.
Some B cells become Memory B cells, which help speed up future responses to the same antigen.
Plasma Cells:
Produce antibodies specific to the antigen upon activation.
Introduction of Antigen:
Antigen is introduced into the body through vaccination.
Antibody Production:
The immune response activates and produces antibodies.
Preparedness for Natural Exposure:
If the horse encounters the actual pathogen later, pre-existing antibodies will combat it effectively.
Disease Prevention:
Vaccines significantly reduce the risk of dangerous infections.
They work by assisting the body's natural defenses, ensuring the development of immunity.
Immune System Stimulation:
Vaccines nearly never cause illness but stimulate the production of T-lymphocytes and antibodies.
They provide beneficial memory cells for long-term immunity.
IgM: Main antibody for primary responses, important for fixing complement.
IgG: Primary antibody for secondary responses; critical for phagocyte binding.
IgA: Found in mucosal areas such as saliva and tears; tags pathogens for destruction.
IgD: Functions mainly as a B-cell receptor; stimulates IgM release.
IgE: Involved in allergic reactions and antiparasitic activity; binds to basophils and mast cells.
Primary Response:
Initial antibody response is dominated by IgM; later shifts to IgG.
Time frame: 10 to 20 days post-exposure for antibody production.
Secondary Response:
Rapid increase in IgG due to the presence of memory cells, indicating a quicker response.
IgA:
Found in mucous membranes and fluids such as saliva and breastmilk. Important for mucosal immunity.
Companion Animals:
To ensure health and welfare.
Livestock:
Improve overall production and reduce zoonotic disease risk.
Wildlife:
Manage zoonotic diseases and preserve species.
Adjuvant:
Substance added to enhance the immune response to vaccines.
Live Attenuated Vaccines:
Weakened pathogens stimulate strong immune responses with lower risks.
Inactivated Vaccines:
Non-live pathogens provide safer alternatives but may require boosters.
Toxoid Vaccines:
Inactivated toxins induce immunity against toxins produced by pathogens.
Subunit Vaccines:
Focus on specific parts of the pathogen to elicit immune response.
Conjugate Vaccines:
Combine polysaccharides (weak antigens) with proteins (strong antigens) for enhanced immune response.
Nasal Mucosa:
High vascularization makes it effective; avoids injection-related issues.
Intramuscular (IM) and Subcutaneous (SC):
Suitable traditional routes with various local side effects and immune response features.
Vaccines for various target pathogens available through various distributors (Boehringer-Ingelheim, Pfizer, etc.).
Specific vaccines labeled for animals such as pigs, dogs, fish, horses, and chickens targeting bacteria like Lawsonia intracellularis, Bordetella spp., Salmonella, etc.
Characteristics:
Colonizes the respiratory tract of dogs causing conditions like kennel cough. Commonly vaccinated against due to infection risk to cats.
Vaccine Options:
Intranasal (IN) or parenteral (SC) with rapid immunity onset and prolonged effects.
Animal-Related Factors:
Conditions that can impact immune response include immunosuppression, genetic influences, and heavy exposure to pathogens.
Vaccine-Related Factors:
Include storage conditions, expiration, and reconstitution practices affecting vaccine potency and effectiveness.
Importance of understanding and studying bacterial vaccines for effective immunization in veterinary practices.